| Bio Roundup: Lung Cancer Questions, Migraine Races, HIV Battle & More | Ben Fidler | 02/09/18 | National |
| Immunotherapy Safety Worries Halt Celgene Myeloma Study, Slow 5 Others | Alex Lash | 09/07/17 | New York |
| Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer | Ben Fidler | 08/16/17 | New York |
| FDA Halts Merck’s Multiple Myeloma Trials After Patient Deaths | Frank Vinluan | 07/05/17 | New York |
| In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths | Ben Fidler | 06/12/17 | New York |
| ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More | Ben Fidler | 12/06/16 | National |
| Acetylon Crafts New Buyout Deal With Celgene, Spins Out Startup Regenacy | Ben Fidler | 12/02/16 | Boston |
| Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out | Ben Fidler | 08/08/16 | Boston |
| Dunsire Out at Millennium as Takeda Reorganizes, Cuts Costs | Luke Timmerman | 05/09/13 | Boston |
